Jade Biosciences, Inc.
NASDAQ:JBIO · NASDAQ Global Market
-$0.21 today
Vol 3.28M · Avg 0.83M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+70.42%
Period High
$26.85
Period Low
$6.77
Latest
$16.82
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Tectonic Therapeutic, Inc.
NASDAQ:TECX
$561.74M
XOMA Royalty Corp.
NASDAQ:XOMA
$525.59M
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$440.41M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$351.21M
Silence Therapeutics plc
NASDAQ:SLN
$324.97M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$296.11M
AC Immune S.A.
NASDAQ:ACIU
$240.69M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$117.02M
Genelux Corporation
NASDAQ:GNLX
$109.47M
What is the latest JBIO filing?
The latest filing shown is 424B5 dated Jun 3, 2026.
How many recent filings does JBIO have?
Intrinsic Alpha currently shows 20 recent filings for JBIO.
Explore More
Continue the stock analysis
Jump to another research area for this company.